Correlation Between Cullinan Oncology and Tyra Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Tyra Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Tyra Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Tyra Biosciences, you can compare the effects of market volatilities on Cullinan Oncology and Tyra Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Tyra Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Tyra Biosciences.

Diversification Opportunities for Cullinan Oncology and Tyra Biosciences

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cullinan and Tyra is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Tyra Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tyra Biosciences and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Tyra Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tyra Biosciences has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Tyra Biosciences go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Tyra Biosciences

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Tyra Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 1.1 times less risky than Tyra Biosciences. The stock trades about -0.27 of its potential returns per unit of risk. The Tyra Biosciences is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest  1,989  in Tyra Biosciences on August 28, 2024 and sell it today you would lose (371.00) from holding Tyra Biosciences or give up 18.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  Tyra Biosciences

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Tyra Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tyra Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Cullinan Oncology and Tyra Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and Tyra Biosciences

The main advantage of trading using opposite Cullinan Oncology and Tyra Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Tyra Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tyra Biosciences will offset losses from the drop in Tyra Biosciences' long position.
The idea behind Cullinan Oncology LLC and Tyra Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios